State of New Jersey Common Pension Fund D’s Protagonist Therapeutics PTGX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.02M	Sell	16,506 -586	-3%	-$61.2K	0.01%	1048
2026 Q1	$1.8M	Buy	17,092 +105	+0.6%	+$9.3K	0.01%	1330
2025 Q4	$1.48M	Sell	16,987 -20,969	-55%	-$1.72M	0.01%	1377
2025 Q3	$2.52M	Sell	37,956 -3,069	-7%	-$174K	0.01%	876
2025 Q2	$2.27M	Sell	41,025 -12,711	-24%	-$610K	0.01%	874
2025 Q1	$2.6M	Buy	+53,736	New	+$2.25M	0.01%	766
2021 Q4	–	Sell	-54,589	Closed	-$967K	–	1788
2021 Q3	$967K	Buy	+54,589	New	+$2.33M	﹤0.01%	1694

Other funds holding PTGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $116B AUM 61.47% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State of New Jersey Common Pension Fund D's PTGX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Protagonist Therapeutics (PTGX) stake by 3.4% in Q2 2026, selling an estimated $61.2K and leaving 16,506 shares worth $2.02M. The position accounts for 0.01% of the portfolio, ranked #1048.

State of New Jersey Common Pension Fund D first reported a position in PTGX in Q3 2021 and has held it in 7 quarters since. The position peaked at $2.6M in Q1 2025. 195 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

State of New Jersey Common Pension Fund D held 16,506 shares of Protagonist Therapeutics worth $2.02M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 586 Protagonist Therapeutics shares in Q2 2026, an estimated $61.2K.
Protagonist Therapeutics made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1048 holding.
State of New Jersey Common Pension Fund D first reported a position in Protagonist Therapeutics in Q3 2021 and has held it in 7 quarters since.
State of New Jersey Common Pension Fund D's Protagonist Therapeutics position peaked at $2.6M in Q1 2025.
195 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.